- Home
- XAIR vs GLMD Comparison
XAIR vs GLMD Comparison
Compare XAIR & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XAIR | GLMD |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.2M |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | XAIR | GLMD |
|---|---|---|
| Price | $3.08 | $4.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 131.0K | 71.7K |
| Earning Date | 06-16-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,679,000.00 | N/A |
| Revenue This Year | $122.00 | N/A |
| Revenue Next Year | $58.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 107.26 | N/A |
| 52 Week Low | $0.33 | $0.41 |
| 52 Week High | $8.19 | $5.45 |
Technical Indicators
Market Signals| Indicator | XAIR | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 75.44 |
| Support Level | $0.55 | $0.54 |
| Resistance Level | $7.09 | $5.45 |
| Average True Range (ATR) | 0.42 | 0.35 |
| MACD | -0.17 | -0.03 |
| Stochastic Oscillator | 1.47 | 84.83 |
Price Performance
Historical ComparisonAbout XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.